Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antony Clark

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical & Experimental Ophthalmology|July 24, 2010
Diabetic retinopathy and the major causes of vision loss in Aboriginals from remote Western AustraliaAntony Clark, William H Morgan, Sam Kain, et al.
The British Journal of Ophthalmology|November 19, 2011
Prevalence of blindness in Western Australia: a population study using capture and recapture techniquesJulie Crewe, William H Morgan, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|October 27, 2010
Diabetic retinopathy management by Australian optometristsDaniel S W Ting, Jonathon Q Ng, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|February 24, 2024
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia - Atropine for the Treatment of Myopia (WA-ATOM) studySamantha Sze-Yee Lee, Vinay Kumar Nilagiri, Gareth Lingham, et al.
Clinical & Experimental Ophthalmology|November 13, 2010
Quality of life of the most severely vision-impairedJulie M Crewe, Nigel Morlet, William H Morgan, et al.
Clinical & Experimental Ophthalmology|March 2, 2013
Hospitalization rates of children who are blindJulie M Crewe, Geoff Lam, Antony Clark, et al.
Clinical & Experimental Ophthalmology|August 9, 2011
Assessing the diagnostic validity of a blind registerJulie M Crewe, William H Morgan, Nigel Morlet, et al.
Retina (Philadelphia, Pa.)|March 16, 2013
Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: a whole population studyAnna Kemp, David B Preen, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|September 2, 2022
Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trialSamantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska, et al.
Clinical & Experimental Ophthalmology|February 27, 2020
Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristicsSamantha S Y Lee, David A Mackey, Gareth Lingham, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical & Experimental Ophthalmology|July 24, 2010
Diabetic retinopathy and the major causes of vision loss in Aboriginals from remote Western AustraliaAntony Clark, William H Morgan, Sam Kain, et al.
The British Journal of Ophthalmology|November 19, 2011
Prevalence of blindness in Western Australia: a population study using capture and recapture techniquesJulie Crewe, William H Morgan, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|October 27, 2010
Diabetic retinopathy management by Australian optometristsDaniel S W Ting, Jonathon Q Ng, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|February 24, 2024
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia - Atropine for the Treatment of Myopia (WA-ATOM) studySamantha Sze-Yee Lee, Vinay Kumar Nilagiri, Gareth Lingham, et al.
Clinical & Experimental Ophthalmology|November 13, 2010
Quality of life of the most severely vision-impairedJulie M Crewe, Nigel Morlet, William H Morgan, et al.
Clinical & Experimental Ophthalmology|March 2, 2013
Hospitalization rates of children who are blindJulie M Crewe, Geoff Lam, Antony Clark, et al.
Clinical & Experimental Ophthalmology|August 9, 2011
Assessing the diagnostic validity of a blind registerJulie M Crewe, William H Morgan, Nigel Morlet, et al.
Retina (Philadelphia, Pa.)|March 16, 2013
Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: a whole population studyAnna Kemp, David B Preen, Nigel Morlet, et al.
Clinical & Experimental Ophthalmology|September 2, 2022
Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trialSamantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska, et al.
Clinical & Experimental Ophthalmology|February 27, 2020
Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristicsSamantha S Y Lee, David A Mackey, Gareth Lingham, et al.
Pageof 4